APD — Air Products and Chemicals, Inc.

Market sentiment is constructive: the Q3 FY2026 adjusted EPS beat at $3.47, management raised full-year adjusted EPS guidance to $13.39-$13.49, and analysts have a consensus Buy with an average target around $346. The GAAP loss of -$6.46 is being treated as a one-time portfolio cleanup rather than a deterioration in the core gases business.

Revenue has been remarkably stable in a $2.9B-$3.2B range for three years; the latest quarter came in at $3.161B, up 4.6% YoY. Gross margin has stayed around 31-33%. Underlying operating income has generally run in the $640-$790M range, but two quarters were heavily distorted by non-recurring items: Mar-2025 had a $2.3B operating loss and Jun-2026 had a $2.1B operating loss tied to project exits. Adjusted EPS is inflecting upward, and operating cash flow jumped 52.5% YoY to $1.305B in the latest quarter, so the trend is stabilizing/improving beneath the noise.

Trailing GAAP valuation is meaningless: P/E TTM is -1468.6 and EPS TTM is -$0.21, both driven by impairment charges. On normalized forward earnings, APD trades at roughly 22.8x next-fiscal-year EPS of $13.424, slightly below its own 5-year average P/E of 23.94. Price-to-sales of 5.4 is a bit above the 5-year average of 5.02, so the stock is roughly fairly valued rather than clearly cheap.

At $305.47, the market is pricing in steady execution of ~$13.40 of adjusted EPS with modest growth, not a clean-energy windfall or a distressed business. If APD delivers FY2027 EPS near $13.42 and the multiple normalizes to its 5-year average of ~24x, fair value lands in the low-$320s. Upside toward analyst targets around $346 requires either EPS beats or a re-rating from improved free cash flow; downside would come if capex keeps draining cash and debt keeps rising, pushing the multiple toward ~20x and a price near $268.

As of 2026-08-27, RSI stands at 55.07, which is neutral, not overbought or oversold. The stock is 0.95% above its 20-day SMA, 2.8% above its 50-day SMA, and 8.67% above its 200-day SMA, so the trend is up but not extended. A break above the 52-week high of $314.87 would open further upside; a pullback toward the 50-day near $297 would improve the entry risk/reward.

• High interest rates raise the cost of capital for capital-intensive hydrogen and industrial gas projects, though APD's capex cuts reduce that pressure.
• EU RED III regulation is boosting demand for certified renewable hydrogen, supporting agreements like the Nobian supply deal.
• Semiconductor/electronics demand in Asia is driving new air separation unit contracts and volume growth.
• Persistent European industrial softness and helium pricing weakness are acting as a drag on base volumes.
• Sector rotation into basic materials and green-hydrogen themes has helped APD outperform year-to-date.

• Q4 and full-year FY2026 earnings in late October/early November 2026, including initial FY2027 guidance.
• Continued ramp and offtake execution at the NEOM green hydrogen project with Yara International.
• Progress on the Taiwan semiconductor air separation unit contract and the ~$3B industrial gas project backlog.
• Further evidence of free cash flow improvement as capex is cut to roughly $3.5B.
• Next quarterly dividend of $1.81 per share, ex-dividend October 1, 2026.

• Execution and financing risk on NEOM and other clean-energy projects, which remain unproven at scale.
• High leverage: debt-to-equity is 1.31 and long-term debt is $16.8B, while free cash flow has been negative in most recent quarters.
• Additional write-downs or cost overruns in the remaining hydrogen/clean-energy portfolio.
• Weak European industrial demand and continued helium price softness could pressure margins.
• Delays in electronics/semiconductor ramps could slow the highest-quality growth segment.

APD is a high-quality industrial gas franchise at a roughly fair price. The GAAP loss is mostly a deliberate cleanup of bad clean-energy bets, while the core business is generating stable adjusted EPS around $13.40 and raising guidance. The main issue is balance sheet and free cash flow: debt is high and FCF has been negative, so the stock is not a clear bargain. I would not chase it here, but the risk/reward is balanced and improves on a pullback toward the 50-day moving average.

I calculated fair value by applying APD's 5-year average P/E of 23.94 to next-fiscal-year estimated adjusted EPS of $13.424, after treating the $2.9B charge as non-recurring and using the company's own historical average multiple rather than the current 22.8x forward multiple. This produces a fair value of $321.43, slightly above the current price of $305.47.